The Regenerative Medicine Institute was established at NUI Galway and partner academic institutions in 2004 with funding obtained from Science Foundation Ireland. REMEDI’s vision is to develop cellular therapies to promote organ and tissue repair and regeneration thus avoiding the need for replacement. To achieve this, the REMEDI translational research programme has a mission to conduct basic research in fundamental stem cell biology and to translate and commercialise research outputs by developing regenerative medicine therapies for diseases such as; cardiovascular disease, diabetes mellitus and osteoarthritis. Supporting the realization of our vision are the strategic partnerships REMEDI has forged with academics, the health service and industry.